Breaking New Ground in Gene Therapy: Tune Therapeutics Secures $175 Million to Revolutionize Genetic Disease Treatment

Tune Therapeutics, a pioneering biotech startup based in Seattle, has secured $175 million in funding to advance its revolutionary work in gene regulation. This substantial investment highlights the growing confidence in gene therapy solutions and their potential to transform medical treatments. The landmark funding round attracted major venture capital firms and pharmaceutical companies, positioning Tune Therapeutics for significant expansion. The company will direct these resources toward developing precision medicines for previously challenging genetic disorders. At the core of Tune T